JP2019517590A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517590A5
JP2019517590A5 JP2019516293A JP2019516293A JP2019517590A5 JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5 JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5
Authority
JP
Japan
Prior art keywords
active agent
composition
condition
porous
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019516293A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517590A (ja
JP7542309B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/053288 external-priority patent/WO2017208209A1/en
Publication of JP2019517590A publication Critical patent/JP2019517590A/ja
Publication of JP2019517590A5 publication Critical patent/JP2019517590A5/ja
Priority to JP2022067716A priority Critical patent/JP7571078B2/ja
Application granted granted Critical
Publication of JP7542309B2 publication Critical patent/JP7542309B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019516293A 2016-06-03 2017-06-02 多孔性賦形剤を含む経鼻用医薬組成物 Active JP7542309B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022067716A JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345369P 2016-06-03 2016-06-03
US62/345,369 2016-06-03
PCT/IB2017/053288 WO2017208209A1 (en) 2016-06-03 2017-06-02 Nasal pharmaceutical compositions with a porous excipient

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022067716A Division JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Publications (3)

Publication Number Publication Date
JP2019517590A JP2019517590A (ja) 2019-06-24
JP2019517590A5 true JP2019517590A5 (https=) 2020-07-16
JP7542309B2 JP7542309B2 (ja) 2024-08-30

Family

ID=59078127

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019516293A Active JP7542309B2 (ja) 2016-06-03 2017-06-02 多孔性賦形剤を含む経鼻用医薬組成物
JP2022067716A Active JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022067716A Active JP7571078B2 (ja) 2016-06-03 2022-04-15 多孔性賦形剤を含む経鼻用医薬組成物

Country Status (11)

Country Link
US (1) US11903951B2 (https=)
EP (1) EP3463375A1 (https=)
JP (2) JP7542309B2 (https=)
KR (1) KR102387241B1 (https=)
CN (1) CN109803663A (https=)
AU (1) AU2017274649B2 (https=)
EA (1) EA201892595A1 (https=)
MX (1) MX389588B (https=)
SG (1) SG11201810628XA (https=)
WO (1) WO2017208209A1 (https=)
ZA (1) ZA201808551B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190109452A (ko) 2017-01-20 2019-09-25 엠 이티 피 파마 아게 대기 오염 물질에의 노출 위험을 감소시키기 위한 비강 약학적 조성물
CA3087840A1 (en) 2018-01-11 2019-07-18 M et P Pharma AG Treatment of demyelinating diseases
WO2019141267A1 (zh) * 2018-01-22 2019-07-25 北京茵诺医药科技有限公司 用于靶向活化cd44分子的重组仿生纳米载体递送系统、其制备方法和用途
CA3097090A1 (en) * 2018-04-17 2019-10-24 M et P Pharma AG Compositions and methods for intranasal delivery of pregnenolone
US10988491B2 (en) 2018-08-17 2021-04-27 Massachusetts Institute Of Technology Degradable polymers of a cyclic silyl ether and uses thereof
EP4058501A1 (en) 2019-11-15 2022-09-21 Massachusetts Institute of Technology Functional oligomers and functional polymers including hydroxylated polymers and conjugates thereof and uses thereof
JP2023504876A (ja) * 2019-12-06 2023-02-07 シャンハイ ファーマシューティカルズ ホールディング カンパニー,リミティド 薬物組成物、キット及びその応用
PT3962455T (pt) 2020-05-18 2022-10-13 Orexo Ab Nova composição farmacêutica para entrega de fármacos
JP2021000484A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
JP2021000483A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
JP2021000481A (ja) * 2020-09-15 2021-01-07 株式会社三洋物産 遊技機
CN112263546B (zh) * 2020-09-29 2021-08-10 南京大学 通过鼻腔给药的佐匹克隆混悬液纳米制剂及其制备方法
EP4284854A1 (en) 2021-02-01 2023-12-06 Massachusetts Institute of Technology Reprocessable compositions
CN112972428B (zh) * 2021-03-09 2022-03-08 石河子大学 两性离子聚合物膜包覆的介孔硅基药物载体及制备方法
CN113456576B (zh) * 2021-06-28 2022-09-16 华中科技大学 纳米材料用于制备鼻腔纳米制剂脑靶向递送肠道药物应用
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
JP2025511227A (ja) * 2022-04-01 2025-04-15 エナラーレ セラピューティクス インコーポレイテッド 呼吸器刺激性経鼻製剤
CN115505052B (zh) * 2022-08-23 2023-05-23 安徽普利药业有限公司 一种β-环糊精衍生物的制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002597A (en) 1989-04-03 1991-03-26 Invent Ag Aerodynamic filter
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE19701912C1 (de) * 1997-01-10 1998-05-14 Jenapharm Gmbh Injizierbares Implantat
DE10064950A1 (de) 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
US7563451B2 (en) * 2003-07-22 2009-07-21 Iowa State University Research Foundation, Inc. Capped mesoporous silicates
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
ATE319426T1 (de) 2003-11-11 2006-03-15 Mattern Udo Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
EP1933811A2 (en) * 2005-09-30 2008-06-25 Alza Corporation Banded controlled release nanoparticle active agent formulation dosage forms and methods
CA2664427C (en) 2006-10-04 2012-06-05 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal application of neurotransmitters
CN101522100B (zh) 2006-10-13 2012-02-08 皇家飞利浦电子股份有限公司 可切换的关节约束系统
US8258137B2 (en) * 2008-01-29 2012-09-04 Katholieke Universiteit Leuven Process for release of biologically active species from mesoporous oxide systems
KR20180089553A (ko) 2008-09-23 2018-08-08 라보라토리 스킨 케어, 인크. 활성제 장입된 균일하고 강성이면서 구형의 나노다공성 인산칼슘 입자 및 그의 제조 방법과 그의 용도
JP2012506904A (ja) * 2008-10-28 2012-03-22 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 難水溶性成分のためのメソ多孔性材料賦形剤
CN103687587A (zh) 2011-05-13 2014-03-26 特利默生物医药有限公司 鼻内较低剂量强度睾酮凝胶制剂及其用于治疗性快感缺失病或性欲减退疾患的应用
US20130040922A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
BR112013029332A2 (pt) 2011-05-15 2021-06-01 Trimel Biopharma Srl formulações de gel bioadesivas de testosterona intranasais e uso das mesmas para tratar hipogonadismo de indivíduo do sexo masculino
ITTO20111242A1 (it) * 2011-12-30 2013-07-01 Miso S R L Composizioni per il trattamento di patologie delle mucose
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US20150297733A1 (en) * 2012-11-14 2015-10-22 Trimel Biopharma Srl Controlled release topical testosterone formulations and methods
WO2014080283A2 (en) * 2012-11-21 2014-05-30 Trimel Biopharma Srl Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt
WO2015066717A1 (en) * 2013-11-04 2015-05-07 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
WO2016041992A1 (en) 2014-09-15 2016-03-24 Grace Gmbh & Co. Kg Active-loaded particulate materials for topical administration
ES2802530T3 (es) 2015-08-04 2021-01-20 Windstar Medical Gmbh Una composición nasal
EP3347124A1 (en) 2015-09-09 2018-07-18 King Abdullah University Of Science And Technology Functionalized sio2 microspheres for extracting oil from produced water
EP3229549B1 (en) * 2016-04-08 2018-11-21 Panasonic Intellectual Property Corporation of America Procedures for grouping wearable devices with lte master ues
KR20190109452A (ko) 2017-01-20 2019-09-25 엠 이티 피 파마 아게 대기 오염 물질에의 노출 위험을 감소시키기 위한 비강 약학적 조성물

Similar Documents

Publication Publication Date Title
JP2019517590A5 (https=)
JP7571078B2 (ja) 多孔性賦形剤を含む経鼻用医薬組成物
JP7366178B2 (ja) 鼻腔内薬学的粉末組成物
CN102046153B (zh) 包含布立西坦的药物组合物
EP1406593B1 (en) Biodegradable polymer compositions, compositions and uses related thereto
EP1803446B1 (en) Orally disintegrating tablet and method of preparation
ES2517244T3 (es) Forma farmacéutica hinchable que comprende goma gellan
JP5600058B2 (ja) メラトニンタブレットならびに調剤及び使用方法
CN101400343B (zh) 含有药物-离子交换树脂复合物的经修饰释放的制剂
CN107811980B (zh) 快速溶解固体剂型
JP2014506583A5 (https=)
US20210386858A1 (en) Mucoadhesive compositions and uses thereof
Domínguez-Delgado et al. Drug Carrier Systems Using Chitosan for Non Parenteral
CN117098533A (zh) γ-羟基丁酸衍生物的组合释放型制剂的药物动力学
CN118829647A (zh) 白介素-23受体的肽抑制剂及其药物组合物
CN107205950A (zh) 金刚烷胺组合物的施用方法
JP2005508872A5 (https=)
CN1921888A (zh) 盐酸坦舒洛新的口服组合物和包含该组合物的控释颗粒制剂
WO2021108801A2 (en) Long acting nmda antagonists
Elmowafy et al. Polysaccharide-based platforms for nasal delivery: design, features, and perspectives
KR20140003544A (ko) 약제학적 제제
CN105377303A (zh) 口腔崩解片
JP2015529196A5 (https=)
CA3026041C (en) Nasal pharmaceutical compositions with a porous excipient
CN102600095B (zh) 一种氨溴索缓释制剂及其制备方法